- Home
- RA vs CBLL Comparison
RA vs CBLL Comparison
Compare RA & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RA
- CBLL
- Stock Information
- Founded
- RA 2016
- CBLL 2014
- Country
- RA United States
- CBLL United States
- Employees
- RA 1260
- CBLL N/A
- Industry
- RA Investment Managers
- CBLL
- Sector
- RA Finance
- CBLL
- Exchange
- RA Nasdaq
- CBLL Nasdaq
- Market Cap
- RA 711.7M
- CBLL 710.2M
- IPO Year
- RA N/A
- CBLL 2024
- Fundamental
- Price
- RA $13.19
- CBLL $15.58
- Analyst Decision
- RA
- CBLL Strong Buy
- Analyst Count
- RA 0
- CBLL 6
- Target Price
- RA N/A
- CBLL $33.00
- AVG Volume (30 Days)
- RA 280.8K
- CBLL 339.4K
- Earning Date
- RA 01-01-0001
- CBLL 08-14-2025
- Dividend Yield
- RA 14.73%
- CBLL N/A
- EPS Growth
- RA N/A
- CBLL N/A
- EPS
- RA N/A
- CBLL N/A
- Revenue
- RA N/A
- CBLL $71,535,000.00
- Revenue This Year
- RA N/A
- CBLL $33.98
- Revenue Next Year
- RA N/A
- CBLL $28.82
- P/E Ratio
- RA N/A
- CBLL N/A
- Revenue Growth
- RA N/A
- CBLL 44.86
- 52 Week Low
- RA $11.89
- CBLL $10.01
- 52 Week High
- RA $17.32
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- RA 52.29
- CBLL N/A
- Support Level
- RA $13.25
- CBLL N/A
- Resistance Level
- RA $13.40
- CBLL N/A
- Average True Range (ATR)
- RA 0.08
- CBLL 0.00
- MACD
- RA -0.02
- CBLL 0.00
- Stochastic Oscillator
- RA 1.08
- CBLL 0.00
About RA Brookfield Real Assets Income Fund Inc.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities. The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.